Summary
Detection of micrometastases in patients with solid tumours may aid the establishment of prognosis and development of new therapeutic approaches. This study was designed to investigate the presence and frequency of tumour cells in the peripheral blood (PB) of patients with breast or ovarian cancer by using a combination of magnetic activated cell sorting (MACS) and fluorescence in situ hybridization (FISH). Separated tumour cell and PB-samples from 48 patients (35 breast cancers, 12 ovarian tumours, one uterine sarcoma) were analysed for the presence of numerical aberrations of chromosomes 7, 12, 17 and 17 q11.2–q12. Twenty-five patients had primary disease and 23 had relapsed. The technique allows the detection of one tumour cell in 106 normal cells. Circulating tumour cells were detected in 35/48 cases (17 patients had relapsed and 13 primary carcinoma with lymph node or solid metastases) by the expression of anti-cytokeratin and the presence of numerical chromosomal abnormalities. PB-tumour cells of patients with a primary carcinoma and without solid metastases had a significantly lower percentage of chromosomal aberrations, especially for chromosome 12 (P = 0.035; P = 0.038) compared to those with relapsed disease and solid metastases. Detection and quantification of minimal residual disease may monitor the response to cytotoxic or hormonal therapy and may identify women at risk of relapse.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
An, HX, Niederacher, D, Beckmann, MW, Gohring, UJ, Scharl, A, Picard, F, van Roeyen, C, Schnurch, HG & Bender, HG (1995). ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissues. Int J Cancer 64: 291–297.
Berois, N, Varangot, M, Osinaga, E, Babino, A, Caignault, L, Muse, I & Roseto, A (1997). Detection of rare human breast cancer cells. Comparison of an immunomagnetic separation method with immunocytochemistry and RT-PCR. Anticancer Res 17: 2639–2646.
Bostick, PJ, Chatterjee, S, Chi, DD, Huynh, KT, Giuliano, AE, Cote, R & Hoon, DS (1998). Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16: 2632–2640.
Cajulis, RS, Kotliar, S, Haines, GK, Frias-Hidvegi, D & O’Gorman, M (1994). Comparative study of interphase cytogenetics, flow cytometric analysis, and nuclear grade of fine-needle aspirates of breast carcinoma. Diagn Cytopathol 11: 151–158.
Datta, YH, Adams, PT, Drobyski, WR, Ethier, SP, Terry, VH & Roth, MS (1994). Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12: 475–482.
Deville, P, Theirry, RF, Kievitis, T, Kolluri, R, Hopman, AHN, Willard, HF, Pearson, PL & Cornelisse, CJ (1988). Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. Cancer Res 48: 5825–5830.
Cote, RJ, Rosen, PP, Lesser, ML, Old, LJ & Osborne, MP (1991). Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9: 1749–1756.
Cote, RJ, Beattie, EJ, Chaiwun, B, Shi, SR, Harvey, J, Chen, SC, Sherrod, AE, Groshen, S & Taylor, CR (1995). Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann Surg 4: 415–423.
Cote, RJ, Houchens, DP, Hitchcock, CL, Saad, AD, Nines, RG, Greenson, JK, schneebaum, S, Arnold, MW & Martin, EW Jr (1996). Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabeled monoclonal antibody CC49. Cancer 77: 613–620.
Diel, IJ, Kaufmann, M, Costa, SD, Holle, R, von Minckwitz, G, Solomayer, EF, Kaul, S & Basetert, G (1996). Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 88: 1652–1658.
Dutrillaux, B, Gerbault-Seureau, M & Zafrani, B (1990). Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paraploid cases with few chromosome changes. Cancer Genet Cytogenet 49: 203–217.
Eaton, MC, Hardingham, JE, Kotasek, D & Dobrovik, A (1997). Immunobead RT-PCR: a sensitive detection method for detection of circulating tumor cells. Biotechniques 22: 100–105.
Engel, H, Friedrich, J, Kleespies, C, Kurbacher, CM, Schöndorf, T, Grecu, O, Kolhagen, H & Mallmann, P (1998). Detection of chromosomal aberrations in tumor cells and tumor infiltrating lymphocytes by molecular cytogenetics in patients with gynecological cancer. Cancer Genet Cytogenet 106: 159–165.
Fernandez, JL, Goyanes, V, Lopez-Fernandez, C, Buno, I & Gosalvez, J (1996). Quantification of C-ERB-B2 gene amplification in breast cancer cells using fluorescence in situ hybridization and digital image analysis. Cancer Genet Cytogenet 86: 18–21.
Fiegl, M, Tueni, C, Schenk, T, Jakesz, R, Gnat, M, Reiner, A, Rudas, M, Pirc-Danoewinata, H, Marosi, C & Huber, H (1995). Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer. Br J Cancer 72: 51–55.
Franklin, WA, Shpall, EJ, Archer, P, Johnston, CS, Garza-Williams, S, Hami, L, Bitter, MA, Bast, RC & Jones, RB (1996). Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support. Breast Cancer Res Treat 41: 1–13.
Geleick, D, Müller, H, Matter, A, Torhorst, J & Regenass, U (1990). Cytogenetics of breast cancer. Cancer Genet Cytogenet 46: 217–229.
Harbeck, N, Schwarze, S, Schüren, E, Yamamoto, N, Moniwa, N, Schmitt, M, Dettmar, P, Nathrath, W, Jänicke, F, Höfler, H & Graeff, H (1995). Model system for isolation of competent ovarian carcinoma cells from fresh tumor tissue by magnetic cell separation technique (MACS). Internat J Oncol 6: 1249–1254.
Hardingham, JE, Kotasek, D, Farmer, B, Butler, RN, Mi, JX, Sage, RE & Dobrovic, A (1993). Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res 53: 3455–3458.
Hardingham, JE, Kotasek, D, Sage, RE, Eaton, MC, Pascoe, VH & Dobrovic, A (1995). Detection of circulating tumor cells in colorectal cancer by immunobead_PCR is a sensitive prognostic marker for relapse of disease. Mol Med 1: 789–794.
Helfrich, W, ten Poele, R, Meersma, GJ, Mulder, NH, de Vries, EJ, de Leij, L & Smit, EF (1997). A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood. Br J Cancer 76: 29–35.
Hildebrandt, M, Mapara, MY, Korner, IJ, Bargou, RC, Moldenhauer, G & Dorken, B (1997). Reverse transcriptase-polymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: a sensitive method for monitoring purging efficiency. Exp Hematol 25: 57–65.
Ichikawa, D, Hashimoto, N, Hoshima, M, Yamaguchi, T, Sawai, K, Nakumura, Y, Takahashi, T, Abe, T & Inazawa, J (1996). Analysis of numerical aberrations of specific chromosomes by fluorescence in situ hybridization as a diagnostic tool in breast cancer. Cancer 77: 2064–2069.
Ishikawa, T, Kobayashi, M, Mai, M, Suzuki, T & Ooi, A (1997). Amplification of the c-erbB-2 (Her-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization. Am J Pathol 151: 761–768.
Kallioniemi, OP, Kallioniemi, A, Kursiu, W, Thor, A, Chen, LC, Smith, HS, Waldman, FM, Pinkel, D & Gray, JW (1992). ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 89: 5321–5325.
Kiechle-Schwarz, M, Decker, HJH, Berger, CS, Fiebig, CS & Sandberg, AA (1991). Detection of monosomy in interphase nuclei and identification of marker chromosomes using biotinylated alpha-satellite DNA probes. Cancer Genet Cytogenet 51: 23–33.
Kruger, W, Krzizanowski, C, Holweg, M, Stockschlader, M, Kroger, N, Jung, R, Mross, K, Jonat, W & Zander, AR (1996). Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol 122: 679–686.
Kruger, WH, Stockschlader, M, Hennings, S, Aschenbrenner, M, Gruber, M, Gutensohn, K, Loliger, C, Gieseking, F, Jonat, W & Zander, AR (1996). Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture. Bone Marrow Transplant 18: 18–20.
Kvalheim, G (1996). Detection of occult tumour cells in bone marrow and blood in breast cancer patients – methods and clinical significance. Acta Oncol 35: 13–18.
Le Beau, MM (1993). Detecting genetic changes in human tumor cells: Have scientists ‘gone fishing?’. Blood 81: 1979–1983.
Luppi, M, Morselli, M, Bandieri, E, Federico, M, Marasca, R, Barozzi, P, Ferrari, MG, Savarino, M, Frassoldati, A & Torelli, G (1996). Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene. Ann Oncol 7: 619–624.
Mapara, MY, Körner, IJ, Hildebrandt, M, Bargou, R, Krahl, D, Reichardt, P & Dörken, B (1997). Monitoring of tumor cell purging after highly enriched efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: Comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. Blood 89: 337–344.
Martin, VM, Siewert, C, Scharl, A, Harms, T, Heinze, R, Ohl, S, Radbruch, A, Miltenyi, S & Schmitz, J (1998). Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp Hematol 26: 252–264.
Micale, MA, Visscher, DW, Gulino, SE & Wolman, SR (1994). Chromosomal aneuploidy in proliferative breast disease. Human Pathol 25: 29–35.
Miltenyi, S, Muller, W, Weichel, W & Radbruch, A (1990). High gradient magnetic cell separation with MACS. Cytometry 11: 231–238.
Moscinski, LC, Trudeau, WL, Fields, KK & Elfenbein, GJ (1996). High-sensitive detection of minimal residual breast carcinoma using polymerase chain reaction and primers for cytokeratin 19. Diagn Mol Pathol 5: 173–180.
Muller, P, Weckermann, D, Riethmuller, G & Schlimok, G (1996). Detection of genetic alterations in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridization. Cancer Genet Cytogenet 88: 8–16.
Naume, B, Borgen, E, Beiske, K, Herstad, TK, Ravnas, G, Renolen, A, Trachsel, S, Thrane-Steen, K, Funderud, S & Kvalheim, G (1997). Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J Hematother 6: 103–114.
Noguchi, S, Aihara, T, Motomura, K, Inaji, H, Imaoka, S & Koyama, H (1996). Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification. Am J Pathol 148: 649–656.
Pantel, K (1996). Detection of minimal residual disease in patients with solid tumors. J Hematother 5: 359–367.
Persons, DL, Hartmann, LC, Herath, JF, Keeney, GL & Jenkins, RB (1994). Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors. Am J Clin Pathol 102: 775–779.
Press, MF, Bernstein, L, Thomas, PA, Meisner, LF, Zhou, JY, Ma, Y, Hung, G, Robinson, RA, Harris, C, El-Naggar, AK, Slamon, DJ, Phillips, RN, Ross, JS, Wolman, SR & Flom, KJ (1997). HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol 15: 2894–2904.
Revillion, F, Bonneterre, J & Peyrat, JP (1998). ERBB2 oncogene in human breast cancer and its clinical significance. Eur J Cancer 34: 791–808.
Ross, AA (1998). Minimal residual disease in solid tumor malignancies: a review. J Hematother 7: 9–18.
Sauter, G, Feichter, G, Torhorst, J, Moch, H, Novotna, H, Wagner, U, Durmuller, U & Waldman, FM (1996). Fluorescence in situ hybridization for detecting erbB-2 amplification in breast tumor fine needle aspiration biopsies. Acta Cytol 40: 164–173.
Schildkraut, JM, Collins, NK, Dent, GA, Tucker, JA, Barret, JC, Berchuck, A & Boyd, J (1995). Loss of heterozygosity on chromosome 17q11–21 in cancers of women who have both breast and ovarian cancer. Am J Obstet Gynecol 172: 908–913.
Schoenefeld, A, Luqmani, Y, Smith, D, O’Reilly, S, Shousha, S, Sinnet, HD & Coombes, RC (1994). Detection of breast cancer micrometatases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54: 2986–2990.
Schoenfeld, A, Kruger, KH, Gomm, J, Sinnett, HD, Gazet, JC, Sacks, N, Bender, HG, Luqmani, Y & Coombes, RC (1997). The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer 33: 854–861.
Smith, B, Selby, P, Southgate, J, Pittman, K, Bradley, C & Blair, GE (1991). Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338: 1227–1229.
Traystman, MD, Cochran, GT, Hake, SJ, Kuszynski, CA, Mann, SL, Murphy, BJ, Pirruccello, SJ, Zuvanich, E & Sharp, JG (1997). Comparison of molecular cytokeratin 19 reverse transcriptase polymerase chain reaction (CK19 RT-PCR) and immunocytochemical detection of micrometastatic breast cancer cells in hematopoietic harvests. J Hematother 6: 551–561.
Visscher, DW, Wallis, T & Ritchie, CA (1995). Detection of chromosome aneuploidy in breast lesions with fluorescence in situ hybridization: comparison of whole nuclei to thin tissue sections and correlation with flow cytometric DNA analysis. Cytometry 21: 95–100.
Visscher, DW, Wallis, TL & Crissmann, JD (1996). Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics. Cancer 77: 315–320.
Vrendenburgh, JJ, Silva, O, Tyer, C, DeSombre, K, Abou-Ghalia, A, Cook, M, Layfied, L, Peters, WP & Bast, RC Jr (1996). A comparison of immunohistochemistry, two-color immunofluorescence, and flow cytometry with cell sorting for the detection of micrometastatic breast cancer in the bone marrow. J Hematother 5: 57–62.
Xu, J & Wang, N (1994). Identification of chromosomal structural alterations in human ovarian carcinoma cells using combined GTG-banding and repetitive fluorescence in situ hybridization (FISH). Cancer Genet Cytogenet 74: 1–7.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Engel, H., Kleespies, C., Friedrich, J. et al. Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics. Br J Cancer 81, 1165–1173 (1999). https://doi.org/10.1038/sj.bjc.6690825
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690825
Keywords
This article is cited by
-
Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases
British Journal of Cancer (2012)
-
Enhanced Specificity of Multiplex Polymerase Chain Reaction via CdTe Quantum Dots
Nanoscale Research Letters (2010)
-
Identification of up-regulated genes in human uterine leiomyoma by suppression subtractive hybridization
Cell Research (2002)